Pain Reduction Produced by Different Treatments in Carpal Tunnel Syndrome
Carpal Tunnel Syndrome
About this trial
This is an interventional supportive care trial for Carpal Tunnel Syndrome focused on measuring Ibuprofen, Median nerve neural mobilization, Waiting list control group, Physiotherapy, Pain management
Eligibility Criteria
Inclusion Criteria:
- Participants must be medically diagnosed with unilateral carpal tunnel syndrome (with confirmative electrodiagnostic findings).
- Full understanding of written and spoken Spanish (language).
- Participants must freely consent to participate.
- The presence of positive Phalen an Tinel sings.
- The presence of carpal tunnel syndrome signs and symptoms
Exclusion Criteria:
- The lack to meet inclusion criterions, the presence of cognitive impairment, tumors, cancer, recent (affected) upper limb surgery or trauma, pregnancy, kinesiophobia, deformities of the (affected) upper limb, recent skin injuries or infections (in the affected upper limb), autoimmune inflammatory conditions or flu type symptoms, allergy to ibuprofen, and also: participants must not be (during the present investigation) under any type of pain reducing treatment (conservative, homeopathic, invasive or not invasive).
Sites / Locations
- "Centro Médico y de Especialidades Pediátricas Dr. José Gregorio Hernández "
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
No Intervention
Median nerve neural mobilization
Ibuprofen
Control group
Non pharmaceutical, non invasive, physiotherapy technique; which consists of a passive and repetitive upper limb movement that seeks to induced median nerve gliding and incursions against surrounding connective tissue. Subjects will be treated 5 days per week during a total time lapse of 4 weeks.
Oral tablet pharmaceutical treatment. Participants will be treated with a maximum of 1200 mg per day, subdivided in 3 intakes of 400 mg each 8 hours during a time lapse of 4 weeks.
Waiting list control group. Participants that belong to the no intervention arm will be assigned to a waiting list to receive treatment. The participants will not receive treatment for carpal tunnel syndrome during a time lapse of 4 weeks. After this period of time, participants will begin the best treatment available.